Everything You Always Wanted to Know About KCCQ But Didn’t Know Who to Ask - 2023 Quality Summit Presentation (Non-CE)-Everything You Always Wanted to Know About KCCQ But Didn’t Know Who to Ask

Everything You Always Wanted to Know About KCCQ But Didn’t Know Who to Ask

Video Transcription

Video Summary

The video transcript is a presentation by Dr. Suzanne Arnold about the importance of the Kansas City Cardiomyopathy Questionnaire (KCCQ) in assessing health status and quality of life in patients with heart failure and individuals undergoing transcatheter valve interventions. Dr. Arnold emphasizes that health status is a meaningful outcome for patients and should be measured alongside traditional clinical outcomes. The KCCQ is a disease-specific measure that assesses physical limitations, symptoms, social limitations, self-efficacy, and quality of life. It is a validated tool that can be used clinically to select appropriate patients for intervention and to track their response to treatment. Monitoring changes in the KCCQ score can help identify patients who are not improving as expected and may benefit from additional interventions. Dr. Arnold also discusses challenges in analyzing and interpreting KCCQ data, such as the placebo effect, the interpretation of mean changes, missing data, and the impact of death on data collection. She concludes by highlighting the role of the KCCQ in the TAVR 30-day composite endpoint and its importance in providing a comprehensive assessment of patient outcomes beyond mortality.

Keywords

Kansas City Cardiomyopathy Questionnaire

KCCQ

health status

quality of life

heart failure

transcatheter valve interventions

clinical outcomes

physical limitations

self-efficacy